Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
First Trust Mid Cap Growth AlphaDEX Fund
FNY
$577M
| $1.34M | ﹤0.01% |
43,490
+24,936
| +134% | +$771K |
|
4227
CALL
Copart
CPRT
$30.5B
| $1.34M | ﹤0.01% |
200,800
-339,200
| -63% | -$2.16M |
|
|
CCMP
4228
PUT
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.34M | ﹤0.01% |
25,400
-2,100
| -8% | -$103K |
|
4229
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$405M
| $1.34M | ﹤0.01% |
34,744
-9,908
| -22% | -$381K |
|
4230
PUT
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
| $1.34M | ﹤0.01% |
29,400
+21,400
| +268% | +$950K |
|
4231
CALL
Pricesmart
PSMT
$5.23B
| $1.34M | ﹤0.01% |
16,000
+4,400
| +38% | +$362K |
|
|
KCG
4232
PUT
DELISTED
KCG Holdings, Inc.
KCG
| $1.34M | ﹤0.01% |
86,300
-13,500
| -14% | -$196K |
|
4233
Choice Hotels
CHH
$4.9B
| $1.34M | ﹤0.01% |
29,685
-965
| -3% | -$46.3K |
|
4234
Sonoco
SON
$5.58B
| $1.34M | ﹤0.01% |
25,300
| – | – |
|
|
ALDR
4235
CALL
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.34M | ﹤0.01% |
40,800
-71,200
| -64% | -$2.17M |
|
4236
CALL
Compañía de Minas Buenaventura
BVN
$8.92B
| $1.33M | ﹤0.01% |
96,400
-91,000
| -49% | -$1.27M |
|
4237
Sturm, Ruger & Co
RGR
$595M
| $1.33M | ﹤0.01% |
23,083
-130,930
| -85% | -$8.29M |
|
4238
WisdomTree Europe SmallCap Dividend Fund
DFE
$167M
| $1.33M | ﹤0.01% |
24,058
+10,813
| +82% | +$583K |
|
4239
PUT
Teladoc Health
TDOC
$1.18B
| $1.33M | ﹤0.01% |
72,700
+31,200
| +75% | +$547K |
|
4240
Becton Dickinson
BDX
$51.6B
| $1.33M | ﹤0.01% |
7,585
| – | – |
|
4241
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.74B
| $1.33M | ﹤0.01% |
26,129
-43,429
| -62% | -$2.07M |
|
4242
iShares Core S&P 500 ETF
IVV
$898B
| $1.33M | ﹤0.01% |
+6,110
| New | +$1.33M |
|
|
SGEN
4243
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.33M | ﹤0.01% |
24,600
-5,200
| -17% | -$247K |
|
4244
CALL
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$18.4B
| $1.33M | ﹤0.01% |
+414,000
| New | +$1.07M |
|
|
TEF
4245
PUT
DELISTED
Telefonica
TEF
| $1.33M | ﹤0.01% |
169,511
-5,792
| -3% | -$44.8K |
|
4246
Clean Energy Fuels
CLNE
$359M
| $1.33M | ﹤0.01% |
296,802
+49,379
| +20% | +$188K |
|
4247
W.P. Carey
WPC
$16.1B
| $1.33M | ﹤0.01% |
20,991
+17,972
| +595% | +$1.2M |
|
4248
CALL
Brinker International
EAT
$9.87B
| $1.33M | ﹤0.01% |
26,300
+4,100
| +18% | +$206K |
|
4249
ESCO Technologies
ESE
$7.18B
| $1.33M | ﹤0.01% |
28,560
| – | – |
|
4250
PUT
LKQ Corp
LKQ
$6.46B
| $1.33M | ﹤0.01% |
37,400
+30,100
| +412% | +$1.04M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.